Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed the Initial Stage of PNEUMOSTEM® Phase-II Clinical Trial

NCT01897987 is registered in ClinicalTrials.gov with Medipost Co Ltd. as lead sponsor.

NCT NCT01897987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01897987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed the Initial Stage of PNEUMOSTEM® Phase-II Clinical Trial
Lead sponsor
Medipost Co Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
March 31, 2020
Enrollment
62 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia